The most recent and non-invasive approach for studying early-stage biomarkers is liquid
biopsy. This implies the extraction and analysis of non-solid biological tissues (serum …

Introduction: Minimally invasive methods will augment the clinical approach for establishing
the diagnosis or monitoring treatment response of central nervous system tumors. Liquid …

Simple Summary Despite a substantial increase in publications in recent years, liquid biopsy
from blood, cerebrospinal fluid (CSF), and other body fluids is usually not routinely used in …

This article reviews recent developments in the application of cell-free DNA-based liquid
biopsies to neurological diseases. Over the past few decades, an explosion of interest in the …

Liquid biopsy, as a non-invasive technique for cancer diagnosis, has emerged as a major
step forward in conquering tumors. Current practice in diagnosis of central nervous system …

In recent years, liquid biopsy has emerged as an alternative method to diagnose and
monitor tumors. Compared to classical tissue biopsy procedures, liquid biopsy facilitates the …

Glioblastoma multiforme (GBM) is one of the most lethal primary central nervous system
cancers with a median overall survival of only 12–15 months. The best documented …

The preclinical diagnosis and clinical practice for Alzheimer's disease (AD) based on liquid
biopsy have made great progress in recent years. As liquid biopsy is a fast, low-cost, and …

Obtaining diagnostic specimens, notably to monitor disease course in cancer patients
undergoing therapy, is an emerging area of research, however, with few clinical implications …

Abstract Purpose of Review Personalized medicine is a challenge to improve survival and
quality of life of patients suffering from primary malignant brain tumor. Molecular biology is …